Terminalcare Support Institute Inc. (TYO:7362)
Japan
· Delayed Price · Currency is JPY 807.00
+25.00 (3.20%)
Apr 24, 2025, 3:13 PM JST
TYO:7362 Revenue
In the year 2024, Terminalcare Support Institute had annual revenue of 4.71B JPY with 10.67% growth. Terminalcare Support Institute had revenue of 1.23B in the quarter ending December 31, 2024, with 8.66% growth.
Revenue
4.71B
Revenue Growth
+10.67%
P/S Ratio
0.26
Revenue / Employee
10.44M
Employees
451
Market Cap
1.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.71B | 454.00M | 10.67% |
| Dec 31, 2023 | 4.25B | 152.00M | 3.71% |
| Dec 31, 2022 | 4.10B | 701.00M | 20.62% |
| Dec 31, 2021 | 3.40B | 470.00M | 16.04% |
| Dec 31, 2020 | 2.93B | 545.00M | 22.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,170.61B |
| Takeda Pharmaceutical Company | 4,579.02B |
| Daiichi Sankyo Company | 1,795.99B |
| HOYA Corporation | 838.60B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,329.86B |
| Astellas Pharma | 1,867.63B |
| Shionogi & | 456.87B |